Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Have recent statin trial findings affected the National Cholesterol Education Program guidelines?

Nature Clinical Practice Cardiovascular Medicine volume 1, pages 76–77 (2004)Cite this article

boxed-textGrundy SM et al. (2004) Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 110: 227–239

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cannon CP et al. (2004) Intensive and moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350: 1495–1504

    Article  CAS  Google Scholar 

  2. Nissen S et al. (2004) Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291: 1071–1080

    Article  CAS  Google Scholar 

  3. O'Keefe JH et al. (2004) Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol 43: 2142–2146

    Article  CAS  Google Scholar 

  4. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (2001) Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486–2497

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Director of Preventive Cardiology at the Mid America Heart Institute, and Clinical Professor of Medicine at the University of Missouri, Kansas City, MO, USA

    James H O'Keefe

Authors
  1. James H O'Keefe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James H O'Keefe.

Ethics declarations

Competing interests

JH O’Keefe is a speaker for GlaxoSmithKline, Pfizer Inc., Wyeth, Forest Pharmaceuticals Inc and Novartis AG.

Rights and permissions

Reprints and permissions

About this article

Cite this article

O'Keefe, J. Have recent statin trial findings affected the National Cholesterol Education Program guidelines?. Nat Rev Cardiol 1, 76–77 (2004). https://doi.org/10.1038/ncpcardio0041

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0041

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing